Jason Test Article for image Upload

Oct 29, 2018

2018 10 30 17 04 0931 P1000137 20181031165628

Test article

Astro 2026 Thumb

ASTRO: Psychotherapy after cancer diagnosis tied to lower mortality

September 28, 2026

Free Webinar: CT Contrast Injection Reimagined

Free Webinar: CT Contrast Injection Reimagined

September 22, 2026

$Guang-Yi Sun, MD, of the Chinese Academy of Medical Sciences in Beijing, China, discusses 10-year outcomes of hypofractionated radiotherapy in high-risk breast cancer.$

ASTRO: 10-year outcomes support hypofractionated radiotherapy in breast cancer

September 28, 2026

Astro 2026 Thumb 2

ASTRO: Few patients adhere to long-term hormone therapy after lumpectomy

September 28, 2026

ASTRO: Psychotherapy after cancer diagnosis tied to lower mortality

Patients with depression had an 11% higher risk of cancer-specific mortality compared with those without it.

September 28, 2026

Astro 2026 Thumb

EHR data may miss women eligible for lung cancer screening

By Amerigo Allegretto

Smoking history may be underestimated in over one-third of lung cancer screening-eligible women identified by self-reporting.

September 28, 2026

Woman Chest Pain 400

ASTRO: 10-year outcomes support hypofractionated radiotherapy in breast cancer

While hypofractionated radiotherapy is well established for whole-breast irradiation after breast-conserving surgery, there is little long-term data on its use post-mastectomy.

September 28, 2026

Guang-Yi Sun, MD, of the Chinese Academy of Medical Sciences in Beijing, China, discusses 10-year outcomes of hypofractionated radiotherapy in high-risk breast cancer.

ASTRO: Few patients adhere to long-term hormone therapy after lumpectomy

By Erik L. Ridley

The results provide real-world context for treatment approaches that consider omitting radiation therapy after lumpectomy.

September 28, 2026

Astro 2026 Thumb 2

ASTRO: Fractionated radiosurgery lessens brain metastases recurrence

By Amerigo Allegretto

Focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced recurrence risk.

September 28, 2026

Astro 2026 Thumb 2

ASTRO: Navigator program improves access for African American breast cancer patients

Afua Ofori-Darko, a medical student at Case Western Reserve, presented early phase I results of a structured patient navigation program.

September 28, 2026

ASTRO: Low-dose RT tied to fewer knee replacements

By Amerigo Allegretto

Patients who underwent low-dose RT had longer symptom relief, less joint deterioration, and lower disability risk.

September 27, 2026

Knee Joint Pain 400

ASTRO: Ultra-low-dose RT controls myeloma bone pain

The pain response rate was 59% at four weeks.

September 27, 2026

ASTRO: Limb-sparing care now standard for extremity sarcoma

In the 1970s, over 50% of extremity soft tissue sarcomas were treated by amputation.

September 27, 2026

Thomas DeLaney, MD, delivered a talk at ASTRO September 27 on preserving limbs in patients with extremity sarcoma.

ASTRO: Siemens unveils Accela radiotherapy system

By AuntMinnie.com staff writers

NeoArc allows stereotactic treatment to be delivered within a single breath hold.

September 27, 2026

Siemens Healthineers' Accela radiotherapy system

ASTRO: Proton RT controls high-risk neuroblastoma

Findings support PRT as a strategy to reduce long-term morbidity without compromising oncologic outcomes.

September 26, 2026

Astro 2026 Thumb 2

ASTRO: How does tumor location affect survival in patients with esophageal cancer?

Upper esophageal tumors were associated with the best survival, while middle esophageal location carried significantly worse odds.

September 26, 2026

Astro 2026 Thumb

Page 1 of 252